Journal issues > Issue 5, September 2020 > Highlights of myelodysplastic syndromes and acute myeloid leukemia

Highlights of myelodysplastic syndromes and acute myeloid leukemia

SUMMARY

This report is summarising the key presentations on Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukaemia (AML) from the virtual 2020 EHA meeting. The summary is focusing on novel treatment modalities and updates of important clinical studies in the field.

(BELG J HEMATOL 2020;11(5):216-21)

To read the full artice you have the following options:

* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Hematology in Belgium and Luxembourg with prescription authorisation)

Purchase this article for €3.03

** (for healthcare professionals with prescribing authorisation working outside the field of Hematology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Hematology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)

Top